Co-Founder of U2Fight_World /Long Hauler since 2020

Europe
Joined July 2022
PostX #UniteToFight2024 retweeted
Three other teams are doing trials of low-dose naltrexone: - Marshall-Gradisnik, Griffith University, Australia - Yarred Younger, University of Alabama, USA - David Systrom, Brigham and Women's Hospital, USA Look forward to these results as well.
1) 🇨🇦 The results of Luis Nacul's trial of low-dose naltrexone (LDN) have been published. Unfortunately, it shows that LDN didn't improve fatigue, pain and other symptoms in patients who developed ME/CFS after COVID-19. A brief breakdown of the main results. 👇
4
1
1
16
1,776
PostX #UniteToFight2024 retweeted
University of British Columbia researchers conducted a randomized trial of 160 Long COVID patients. Low-dose naltrexone (LDN) did not significantly improve fatigue, pain, physical activity, or quality of life compared with placebo after 16 weeks. medrxiv.org/content/10.64898…
7
12
69
2,509
PostX #UniteToFight2024 retweeted
Offener Brief an die @Leopoldina Unterstützer: Prof. Dr. Rolf Marschalek @DAGL_ev @SafeAirDocs @_ProtectTheKids @PiratenparteiSH whn.global/offener-brief-des…
3
42
3
88
2,548
PostX #UniteToFight2024 retweeted
"We now know that unique signals of cardiovascular risk in women can be identified years and decades before heart disease develops," writes preventive cardiologist and epidemiologist Sadiya S. Khan time.com/article/2026/10/26/…
6
12
1
36
25,348
PostX #UniteToFight2024 retweeted
SARS-CoV-2 Is Evolving to Become Harder for Naïve B Cells to Recognize! ➡️ Researchers found that naïve human B cells were 3 times less likely to recognize the KP.2 RBD than the original Wuhan-Hu-1 RBD. ➡️ Mutations such as #E484A and #F486P appear to reduce recognition by naïve B-cell receptors, potentially narrowing the pool of B cells available to initiate new antibody responses. ➡️ The bigger picture: SARS-CoV-2 evolution may do more than evade existing antibodies—it may also make it harder for the unexposed immune system to recognize its spike protein in the first place. H/T: @CatchTheBaby biorxiv.org/content/10.64898…
1
24
60
1,028
Long COVID trial design could be improved by incorporating outcomes that address important symptom clusters such as PEM, dysautonomia, MCAS. Clinical assessments, physical tests & biomarkers can supplement PROM measure data. frontiersin.org/journals/pub…
1
1
3
173
Lastly, safety of the intervention is rarely adequately evaluated. We recommend a concerted effort to include patient input at all steps of clinical trial design, execution and evaluation. @MatthiasHauer @BMG_Bund @bmftr_bund
49
PostX #UniteToFight2024 retweeted
Viral Infection‐Induced Epilepsy & Gut Microbiome Crosstalk:viral infections linked to seizures-gut microbial changes. Zika virus (ZIKV), West Nile virus (WNV), herpes simplex virus-1 (HSV-1), in human epileptogenesis, direct microbiome–seizure connections wires.onlinelibrary.wiley.co…
2
4
10
553
PostX #UniteToFight2024 retweeted
Viral traces still in the lungs 84 days later, despite no detectable live virus.
Johns Hopkins researchers found persistent brain inflammation and memory loss in female mice after COVID, driven by increased TLR7 signaling. Blocking TLR7 prevented these effects, revealing a potential Long COVID treatment target. biorxiv.org/content/10.1101/…
2
16
55
1,462
PostX #UniteToFight2024 retweeted
Ganz wichtiger Artikel von @dysclinic & Co. hEDS, MCAS, POTS/Dysautonomie können bei zB Operationen zu unvorhergesehenen Komplikationen führen. Deswegen bekommen Betroffene bei mir entsprechende OP-Informationen ausgehändigt. tandfonline.com/doi/full/10.…
3
28
135
2,661
PostX #UniteToFight2024 retweeted
🔴 TRENDET MIT! 🔥 Alle Infos findet ihr in den Bildern! 🎬 Die ersten Reels sind schon da! Schaut sie euch an und macht mit! 📢 Jetzt auf allen Plattformen! ❤️ #HeyChatGPTMECFS instagram.com/s/aGlnaGxpZ2h0…
1
10
26
567
PostX #UniteToFight2024 retweeted
🔎 Seronegative Sjögren’s deserves the spotlight. Thank you, @lupuscyclopedia, for highlighting this important conversation ahead of #ACR26! We’re also planning a study on seronegative Sjögren’s at KGMU—turning clinical questions into research. As an #ACRAmbassador, I look forward to learning, connecting & sharing insights from ACR Convergence 2026. Join the conversation! #Sjogrens #RheumTwitter
Come to @ACRheum #ACR26 Orlando Convergence to hear more about seronegative #Sjogrens in the huge Sjogrens sessions! rheumatology.org/annual-meet… #ACRambassador
3
9
35
1,408
PostX #UniteToFight2024 retweeted
Tissue-resident macrophages sense colonic stiffening via Piezo1, releasing NGF to sensitize TRPV1+ nociceptors for visceral pain @SciImmunology science.org/doi/10.1126/scii… 🇨🇳
1
27
2
134
11,320
PostX #UniteToFight2024 retweeted
ME oder Psyche Die richtige Diagnose ME/CFS sei med. geboten, sozialrechtlich aber kein Selbstläufer. Die Bewertungssysteme bildeten psych. Störungen deutlich leichter ab als ME/CFS, das nur analog und nur mit sichtbar gemachter PEM bewertet werden könne. anwalt.de/rechtstipps/me-cfs…
9
26
470
PostX #UniteToFight2024 retweeted
YOUR ATTENTION: 🚨Every new COVID-19 (re)infection elevates your cardiovascular risk profile. Even mild cases can raise the odds of a heart attack, stroke, heart failure, and other CV events for months to years afterward. Risk is higher with more severe illness, yes, but it’s certainly not limited to severe disease. Updated vaccination will show some mitigation(infection severity↓) but doesn’t give you a risk-free pass! #AvoidSars2 #AvoidReinfections #UpdateVaccination ➡️Supportive links: 1. Xie et al., Nature Medicine (2022): Long-term cardiovascular outcomes of COVID-19 (elevated risk even in non-hospitalized patients, graded by severity). nature.com/articles/s41591-0… 2. American Heart Association news release (2024) on the UK Biobank analysis (≈2× risk of heart attack/stroke/death for up to 3 years after any COVID-19 infection). newsroom.heart.org/news/covi… 3. Lindgren et al., Journal of Internal Medicine (2026): Nationwide Swedish matched cohort (nearly doubled long-term MACE and death risk in hospitalized cases, persisting beyond year 1). onlinelibrary.wiley.com/doi/… 4. Hadidchi et al., Journal of Human Hypertension (2026): Elevated CV outcomes (including in non-hospitalized patients) among those with pre-existing hypertension. nature.com/articles/s41371-0… 5. CARTESIAN study, European Heart Journal (2025): Accelerated vascular aging / arterial stiffness after COVID-19, including mild cases: academic.oup.com/eurheartj/a… ➡️These five links give a clear progression from the early 2022 data through 2024–2026 confirmation!!
18
498
30
977
19,870
PostX #UniteToFight2024 retweeted
Neue Termine, jeweils 18–20 Uhr via Zoom: • 24.02.2027: ME/CFS – Umgang mit psychiatrischen Fehldiagnosen • 17.03.2027: ME/CFS – Sozialversicherungen und Leistungen • 12.05.2027: ME/CFS – Besonderheiten in der Psychopharmakotherapie Danke für Ihr Verständnis.
2
9
30
616
PostX #UniteToFight2024 retweeted
Anne lebt mit ME/CFS in einem dunklen Raum, komplett isoliert. Sie kann nicht allein essen, nicht zur Toilette – wie hält man das aus? trib.al/QiUFK28
19
68
4
289
36,580
PostX #UniteToFight2024 retweeted
BBC Sport approached @number10gov for a response to my letter to @andyburnham . The @DHSCgovuk responded and unfortunately this statement isn’t anything we didn’t already know. There are also fundamental inaccuracies within it. Please also bear with me; I’ve had an extremely large amount of messages and I’m operating with a very limited capacity. @Ed_Miliband @tessamunt @JoPlattLeigh @KatieFalkingham @BBCSport @BBCNews @UKLabour @ThereForME_UK @YvetteCooperMP
37
156
8
516
11,765